Market News AIOpen the app

PHAR stock news · Pharming Group N.V.

Stories about Pharming Group N.V. (PHAR) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PHAR

Follow Pharming Group N.V. (PHAR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PHAR
Free on the App Store and Google Play, or on the web.
  1. Nov 6, 2026, 3:27 AM ET · Market

    The U.K. has approved Pharming's Joenja to treat kids aged 4 to 11 with APDS.

    Good for PHAR

    The U.K. approved Joenja for children aged 4 to 11 with APDS, expanding its approved age range. This gives Pharming a new group of eligible patients, a positive development.